Tag Archives: NICE
By Guest Blogger | Published: December 10, 2013
By Leela Barham. Collaboration seems to be ‘in’ thing and it’s set to continue in Europe with the European Medicines Agency (EMA) and EUnetHTA agreeing a three-year joint work plan.
By Guest Blogger | Published: December 2, 2013
By Leela Barham. The European Commission mandated that all member states have a plan for rare diseases back in June 2009. With the EC deadline just weeks away, the UK has now finalized its own. But for those who were hoping it would have a clear focus on access to medicines, there’s little to be optimistic about.
By Julian Upton | Published: November 15, 2013
No More Mr NICE Guy: Pharma Takes On the UK’s Drug Watchdog In a joint letter to The Telegraph yesterday, nine of the world’s biggest pharm companies accused the UK’s drug pricing body, the National Institute for Health and Care Excellence (NICE), of blocking too many new and innovative medicines The open letter — signed by representatives [...]
By Guest Blogger | Published: November 6, 2013
By Leela Barham. Long awaited details have been announced in the Heads of Agreement for the latest Pharmaceutical Price Regulation Scheme (PPRS). It’s worth a read in full (and you can find it here) but some highlights are set out here.
By Guest Blogger | Published: October 8, 2013
The Cancer Drugs Fund: Extension to 2016 By Leela Barham The Cancer Drugs Fund (CDF) in England covers the cost of cancer treatments either when the National Institute for Health and Care Excellence (NICE) has said ‘no’, or hasn’t yet come to a view. It started with £50 million and is now £200million a year. The Coalition [...]